Kenneth C. Micetich

1.8k total citations
31 papers, 1.4k citations indexed

About

Kenneth C. Micetich is a scholar working on Oncology, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Kenneth C. Micetich has authored 31 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Surgery and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Kenneth C. Micetich's work include Colorectal Cancer Treatments and Studies (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Kenneth C. Micetich is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Kenneth C. Micetich collaborates with scholars based in United States and Canada. Kenneth C. Micetich's co-authors include Leonard C. Erickson, E. Anthony Jones, Daniel F. Schafer, R. C. Young, J H Hoofnagle, José Costa, Geoffrey Dusheiko, Diane Barnes, Richard I. Fisher and Leonard A. Zwelling and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and JNCI Journal of the National Cancer Institute.

In The Last Decade

Kenneth C. Micetich

30 papers receiving 1.3k citations

Peers

Kenneth C. Micetich
Beodeul Kang South Korea
Jaekyung Cheon South Korea
Ik Joo Chung South Korea
Annette Gouw Netherlands
Dalbir S. Sandhu United States
Ludger Staib Germany
Kenneth C. Micetich
Citations per year, relative to Kenneth C. Micetich Kenneth C. Micetich (= 1×) peers Frank S. Fan

Countries citing papers authored by Kenneth C. Micetich

Since Specialization
Citations

This map shows the geographic impact of Kenneth C. Micetich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth C. Micetich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth C. Micetich more than expected).

Fields of papers citing papers by Kenneth C. Micetich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth C. Micetich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth C. Micetich. The network helps show where Kenneth C. Micetich may publish in the future.

Co-authorship network of co-authors of Kenneth C. Micetich

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth C. Micetich. A scholar is included among the top collaborators of Kenneth C. Micetich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth C. Micetich. Kenneth C. Micetich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eguia, Emanuel, et al.. (2018). Four hundred fifty-three consecutive pancreaticoduodenectomies with pancreaticogastrostomy. The American Journal of Surgery. 218(2). 355–361. 2 indexed citations
2.
Ben‐Josef, Edgar, Katherine A. Guthrie, Anthony B. El-Khoueiry, et al.. (2015). SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma. Journal of Clinical Oncology. 33(24). 2617–2622. 234 indexed citations
3.
El-Khoueiry, Anthony B., Cathryn Rankin, Syma Iqbal, et al.. (2014). S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma. British Journal of Cancer. 110(4). 882–887. 92 indexed citations
4.
Brandt, Whitney S., Sherri Yong, Gerard Abood, et al.. (2013). The depth of post-treatment perirectal tissue invasion is a predictor of outcome in patients with clinical T3N1M0 rectal cancer treated with neoadjuvant chemoradiation followed by surgical resection. The American Journal of Surgery. 207(3). 357–360. 3 indexed citations
5.
El-Khoueiry, Anthony B., Cathryn Rankin, Syma Iqbal, et al.. (2012). SWOG 0941: A phase II study of sorafenib and erlotinib in patients (pts) with advanced gallbladder cancer or cholangiocarcinoma.. Journal of Clinical Oncology. 30(15_suppl). 4113–4113. 4 indexed citations
6.
Sherman, Karen L., et al.. (2009). Sweet's syndrome with neurologic manifestations in a patient with esophageal adenocarcinoma: case report and review of the literature. International Journal of Dermatology. 48(10). 1062–1065. 6 indexed citations
7.
Kindler, Hedy L., Kathryn Bylow, H. S. Hochster, et al.. (2006). A randomized phase II study of bevacizumab (B) and gemcitabine (G) plus cetuximab (C) or erlotinib (E) in patients (pts) with advanced pancreatic cancer (PC): A preliminary analysis. Journal of Clinical Oncology. 24(18_suppl). 4040–4040. 15 indexed citations
8.
Paner, Gladell P., Simone Silberman, Grace Hartman, et al.. (2003). Analysis of signal transducer and activator of transcription 3 (STAT3) in gastrointestinal stromal tumors.. PubMed. 23(3B). 2253–60. 21 indexed citations
9.
Mason, G. Robert, Kenneth C. Micetich, & Gerard V. Aranha. (2001). Long-term survival of a patient with widespread metastases from Barrett's adenocarcinoma. European Journal of Surgical Oncology. 27(5). 509–510. 2 indexed citations
10.
Thomasma, David C., Kenneth C. Micetich, John J. Brems, & David Van Thiel. (1999). The Ethics of Competition in Liver Transplantation. Cambridge Quarterly of Healthcare Ethics. 8(3). 321–329. 1 indexed citations
11.
Micetich, Kenneth C.. (1996). The Ethical Problems of the Open Label Extension Study. Cambridge Quarterly of Healthcare Ethics. 5(3). 410–414. 3 indexed citations
12.
Micetich, Kenneth C.. (1994). Reflection of an IRB Chair. Cambridge Quarterly of Healthcare Ethics. 3(4). 506–509. 5 indexed citations
13.
Sparano, Joseph A., Richard I. Fisher, Margaret C. Sunderland, et al.. (1993). Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alfa-2a in patients with advanced melanoma.. Journal of Clinical Oncology. 11(10). 1969–1977. 134 indexed citations
14.
Micetich, Kenneth C., Bernard W. Futscher, David Koch, Richard I. Fisher, & Leonard C. Erickson. (1992). Phase I Study of Streptozocin- and Carmustine-Sequenced Administration in Patients With Advanced Cancer. JNCI Journal of the National Cancer Institute. 84(4). 256–261. 44 indexed citations
15.
Bar, M H, Mario Sznol, Michael B. Atkins, et al.. (1990). Metastatic malignant melanoma treated with combined bolus and continuous infusion interleukin-2 and lymphokine-activated killer cells.. Journal of Clinical Oncology. 8(7). 1138–1147. 66 indexed citations
16.
Micetich, Kenneth C., et al.. (1989). Exaggerated Response to Insect Bites An Unusual Cutaneous Manifestation of Chronic Lymphocytic Leukemia. International Journal of Dermatology. 28(3). 186–187. 25 indexed citations
17.
Micetich, Kenneth C., et al.. (1989). Inhibition of a Specific DNA Repair System and Nitrosourea Cytotoxicity in Resistant Human Cancer Cells. PubMed. 1(1). 65–73. 58 indexed citations
18.
Micetich, Kenneth C., et al.. (1987). Erythema with features of seborrheic dermatitis and lupus erythematosus associated with systemic 5-fluorouracil.. PubMed. 39(1). 64–6. 9 indexed citations
19.
Micetich, Kenneth C., Diane Barnes, & Leonard C. Erickson. (1985). A comparative study of the cytotoxicity and DNA-damaging effects of cis-(diammino)(1,1-cyclobutanedicarboxylato)-platinum(II) and cis-diamminedichloroplatinum(II) on L1210 cells.. PubMed. 45(9). 4043–7. 96 indexed citations
20.
Micetich, Kenneth C., Leonard A. Zwelling, Paul E. Gormley, & Robert C. Young. (1982). Phase I-II study of m-AMSA administered as a continuous infusion.. PubMed. 66(10). 1813–7. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026